Rheumatology
From the Journals
Abatacept, certolizumab: Best biologics in early RA
The study was the first head-to-head comparison of multiple biologics plus methotrexate vs. active conventional DMARDs plus steroid bridging for...
From the Journals
Biomarkers may help women with RA to decide on medications in pregnancy
Researchers find differences in gene expression before pregnancy that could help women with rheumatoid arthritis choose to stop or continue...
From the Journals
Tool in development aims to steer telehealth visit appropriateness in rheumatology
The model, using patient characteristics as well as provider preferences, suggests when certain visits can be carried out via telehealth.
From the Journals
Anti-acid meds lower strength of systemic sclerosis drug
Weakened bioavailability of mycophenolate mofetil could require adjustments in treatment.
Conference Coverage
Are women and men with rheumatism treated equally?
Compared with men, women receive a diagnosis of rheumatic disease much later and are treated more poorly, research suggests.
News from the FDA/CDC
Intravenous formulation of secukinumab gets FDA approval
This new route of administration is expected to become available during the fourth quarter of 2023.
From the Journals
Adverse event rates compared for colchicine, NSAIDs when starting allopurinol for gout
Patients receiving prophylactic colchicine or NSAIDs with initiation of allopurinol for gout have more adverse events than those who receive no...
From the Journals
More evidence shows COVID-19’s link to risk for autoimmune disease
Patients with more severe COVID-19 that required hospitalization in the ICU were more likely to develop vasculitis, alopecia totalis, and several...
News from the FDA/CDC
FDA approves ninth Humira biosimilar, with interchangeability
The drug, adalimumab-afzb (Abrilada), is the second adalimumab biosimilar approved with interchangeability status. It will be available in late...
Commentary
Rheumatoid arthritis: Five things to know
A healthier lifestyle is associated with a reduced risk of developing rheumatoid arthritis.
From the Journals
PET scan at diagnosis may help to predict aneurysm risk in patients with giant cell arteritis
Patients with aortic inflammation detected by PET were at greater risk for developing aortic aneurysms, particularly thoracic aortic aneurysms.